% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Timus:141658,
author = {Timäus, Charles and Meiser, Miriam and Bandelow, Borwin
and Engel, Kirsten R and Paschke, Anne M and Wiltfang, Jens
and Wedekind, Dirk},
title = {{P}harmacotherapy of borderline personality disorder: what
has changed over two decades? {A} retrospective evaluation
of clinical practice.},
journal = {BMC psychiatry},
volume = {19},
number = {1},
issn = {1471-244X},
address = {Heidelberg},
publisher = {Springer},
reportid = {DZNE-2020-07982},
pages = {393},
year = {2019},
abstract = {The purpose of this study was to assess the pharmacological
treatment strategies of inpatients with borderline
personality disorder between 2008 and 2012. Additionally, we
compared pharmacotherapy during this period to a previous
one (1996 to 2004).Charts of 87 patients with the main
diagnosis of borderline personality disorder receiving
inpatient treatment in the University Medical Center of
Goettingen, Germany, between 2008 and 2012 were evaluated
retrospectively. For each inpatient treatment, psychotropic
drug therapy including admission and discharge medication
was documented. We compared the prescription rates of the
interval 2008-2012 with the interval $1996-2004.94\%$ of all
inpatients of the interval 2008-2012 were treated with at
least one psychotropic drug at time of discharge. All
classes of psychotropic drugs were applied. We found high
prescription rates of naltrexone $(35.6\%),$ quetiapine
$(19.5\%),$ mirtazapine $(18.4\%),$ sertraline $(12.6\%),$
and escitalopram $(11.5\%).$ Compared to 1996-2004, rates of
low-potency antipsychotics, tri-/tetracyclic antidepressants
and mood stabilizers significantly decreased while usage of
naltrexone significantly increased.In inpatient settings,
pharmacotherapy is still highly prevalent in the management
of BPD. Prescription strategies changed between 1996 and
2012. Quetiapine was preferred, older antidepressants and
low-potency antipsychotics were avoided. Opioid antagonists
are increasingly used and should be considered for further
investigation.},
keywords = {Adult / Anticonvulsants: therapeutic use / Antidepressive
Agents: therapeutic use / Antimanic Agents: therapeutic use
/ Antipsychotic Agents: therapeutic use / Borderline
Personality Disorder: drug therapy / Borderline Personality
Disorder: epidemiology / Borderline Personality Disorder:
psychology / Female / Germany: epidemiology /
Hospitalization: trends / Humans / Male / Middle Aged /
Narcotic Antagonists: therapeutic use / Prevalence /
Psychotropic Drugs: therapeutic use / Retrospective Studies
/ Time Factors / Young Adult},
cin = {AG Wiltfang},
ddc = {610},
cid = {I:(DE-2719)1410006},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31830934},
pmc = {pmc:PMC6909459},
doi = {10.1186/s12888-019-2377-z},
url = {https://pub.dzne.de/record/141658},
}